CHD
54
4
WM
74
-5
YUM
43
-6
GM
74
5
IRM
41
3
RIG
43
-7
DAL
84
-3
RRC
52
-6
ROST
57
-3
PFE
14
-7
CTAS
53
-3
DIS
85
3
NAVI
52
-2
CMS
60
2
CVX
43
-3
EFX
30
-8
WU
24
4
KLAC
38
-6
MUR
44
-3
AIZ
82
2
CHD
54
4
WM
74
-5
YUM
43
-6
GM
74
5
IRM
41
3
RIG
43
-7
DAL
84
-3
RRC
52
-6
ROST
57
-3
PFE
14
-7
CTAS
53
-3
DIS
85
3
NAVI
52
-2
CMS
60
2
CVX
43
-3
EFX
30
-8
WU
24
4
KLAC
38
-6
MUR
44
-3
AIZ
82
2
Financhill
Back

Sana Biotechnology Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
2

SANA
Sana Biotechnology

Last Price:
2.35
Seasonality Move:
-3.61%
Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
26.19
Seasonality Move:
20.78%
Sell
2
Sana Biotechnology (SANA) is a Sell

Is Sana Biotechnology a Buy, Sell or Hold?

  • The current Sana Biotechnology [SANA] share price is $2.42. The Score for SANA is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • SANA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.27. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SANA Stock Price Chart

What is Sana Biotechnology's stock price today?

  • The Sana Biotechnology share price today is $2.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SANA is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

SANA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 21.18 Sell
Chaikin Money Flow: -1340762 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.01 - 4.05) Sell
Bollinger Bands (100): (3.76 - 5.72) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 36.3 Sell
Chaikin Money Flow: -4148679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.02 - 28.78) Sell
Bollinger Bands (100): (29.08 - 39.08) Sell

SANA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.86 Sell
20-day SMA: 3.39 Sell
50-day SMA: 3.94 Sell
200-day SMA: 6.5 Sell
8-day EMA: 2.84 Sell
20-day EMA: 3.27 Sell
50-day EMA: 3.92 Sell
200-day EMA: 5.39 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.63 Sell
20-day SMA: 27.95 Sell
50-day SMA: 30.19 Sell
200-day SMA: 43.29 Sell
8-day EMA: 28.09 Sell
20-day EMA: 28.31 Sell
50-day EMA: 30.23 Sell
200-day EMA: 40.03 Sell

Sana Biotechnology Earnings Growth & SANA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.13 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Sana Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):